Compare PHAR & IDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHAR | IDT |
|---|---|---|
| Founded | 1988 | 1990 |
| Country | Netherlands | United States |
| Employees | N/A | 1925 |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2020 | N/A |
| Metric | PHAR | IDT |
|---|---|---|
| Price | $16.46 | $52.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $38.33 | ★ $80.00 |
| AVG Volume (30 Days) | 8.0K | ★ 92.5K |
| Earning Date | 05-07-2026 | 06-04-2026 |
| Dividend Yield | N/A | ★ 0.53% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.04 | $4.34 |
| Revenue Next Year | $2.51 | N/A |
| P/E Ratio | $3,041.22 | ★ $15.10 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.39 | $45.72 |
| 52 Week High | $21.34 | $71.12 |
| Indicator | PHAR | IDT |
|---|---|---|
| Relative Strength Index (RSI) | 45.92 | 62.62 |
| Support Level | $16.35 | $46.85 |
| Resistance Level | $17.49 | $54.02 |
| Average True Range (ATR) | 0.47 | 1.24 |
| MACD | -0.10 | 0.17 |
| Stochastic Oscillator | 2.50 | 76.13 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.